Skip to main content
Clinical Trials/EUCTR2008-005110-41-NL
EUCTR2008-005110-41-NLActive, not recruitingNot Applicable

Circadian Influence on Renal Clearance of Aminoglycosides in cystic fibrosis patients - CIRCA

not applicable0 sites40 target enrollmentStarted: December 10, 2008Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Inclusion criteria :
  • -Age: = 18 years
  • -a diagnosis of cystic fibrosis (ie, sweat chloride _60 mmol/L or a genotype associated with cystic fibrosis)
  • -chronic infection with Pseudomonas aeruginosa with the most recently isolated organism showing sensitivity to tobramycin.
  • -Pulmonary exacerbation as defined by Fuchs and colleagues
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • -use of nephrotoxic drugs (NSAID´s, furosemide, vancomycin)
  • -allergy for aminoglycosides
  • -granulocytopenia (<1,0 x 109/L)
  • -pregnancy
  • -calculated GFR < 40 ml/min
  • -pre-existing hearing impairment (_20 dB hearing level at any two frequencies between 2kHz and 8 kHz on the standard audiogram)

Investigators

Similar Trials